BioCentury | Mar 2, 2021
Deals
March 1 Quick Takes: OrbiMed raises $3.5B for three funds; plus AZ-Junshi and megarounds for WuXi Diagnostics, FogPharma, Tenaya, DTx
...to treat cancer. venBio Managing Partner Corey Goodman joined the company’s board as chairman. New investors Cormorant Asset Management...
...round led by RA Capital with participation from new investors Access Biotechnology, Citadel’s Surveyor Capital, Cormorant Asset Management...
...round led by RA Capital with participation from new investors Access Biotechnology, Citadel’s Surveyor Capital, Cormorant Asset Management...